🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase III, randomized, open-label, multicenter study will evaluate the...
Status
Active Not Recruiting
Location
Alaska Oncology & Hematology, LLC
Start Date
2022-08-03
Trial ID
NCT05306340
Treatments Being Tested
It is estimated that women lose around 20-25% of bone mass during the 5-10 ...
Status
Active Not Recruiting
Location
Odense University Hospital
Start Date
2024-10-14
Trial ID
NCT06789900
Treatments Being Tested
Assuming greater efficacy in the prevention of acute rejection in the EVR a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-12-20
Trial ID
NCT02040584
Treatments Being Tested
This is a prospective, open-label, multicenter, single-arm Phase Ib/II stud...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-01
Trial ID
NCT07435584
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT01864070
Treatments Being Tested
The objective of this project is to determine if mTORC1 inhibition by 24 we...
Status
Completed
Location
University of Wisconsin-Madison
Start Date
2023-03-24
Trial ID
NCT05835999
Primary Objectives: 1. To identify the optimal dose and pharmacokinetics o...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2006-04
Trial ID
NCT00317720
Treatments Being Tested
This trial will study a type of advanced breast cancer (ABC) defined as end...
Status
Recruiting
Location
Medizinische Universität Innsbruck
Start Date
2024-12-05
Trial ID
NCT06382948
Phase Ib / II study to determine the Maximum Tolerated Dose and Recommended...
Status
Completed
Location
Medical University of Graz State Hospital - University Hospital Graz
Start Date
2014-05-15
Trial ID
NCT02123823
Treatments Being Tested
The purpose of this study is to evaluate the safety and optimal dose of RAD...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2005-11
Trial ID
NCT00459186
Treatments Being Tested